Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alzheimer's Disease
|
1843 | 0.590 | 0.600 | 19 | 44908684 | missense variant | T/C | snv | 0.14 | 0.16 | 0.890 | 0.933 | 15 | 2005 | 2019 | ||||
Alzheimer Disease, Early Onset
|
96 | 0.590 | 0.600 | 19 | 44908684 | missense variant | T/C | snv | 0.14 | 0.16 | 0.700 | 1.000 | 8 | 1997 | 2016 | ||||
Alzheimer Disease, Late Onset
|
243 | 0.590 | 0.600 | 19 | 44908684 | missense variant | T/C | snv | 0.14 | 0.16 | 0.040 | 0.750 | 4 | 1994 | 2019 | ||||
High density lipoprotein measurement
|
1440 | 0.590 | 0.600 | 19 | 44908684 | missense variant | T/C | snv | 0.14 | 0.16 | 0.700 | 1.000 | 4 | 2015 | 2018 | ||||
Hypertriglyceridemia
|
169 | 0.590 | 0.600 | 19 | 44908684 | missense variant | T/C | snv | 0.14 | 0.16 | 0.040 | 0.750 | 4 | 1993 | 2004 | ||||
Age related macular degeneration
|
663 | 0.590 | 0.600 | 19 | 44908684 | missense variant | T/C | snv | 0.14 | 0.16 | 0.720 | 1.000 | 3 | 2006 | 2018 | ||||
Dementia
|
176 | 0.590 | 0.600 | 19 | 44908684 | missense variant | T/C | snv | 0.14 | 0.16 | 0.030 | 1.000 | 3 | 2001 | 2018 | ||||
Hyperlipoproteinemia Type III
|
24 | 0.590 | 0.600 | 19 | 44908684 | missense variant | T/C | snv | 0.14 | 0.16 | 0.730 | 1.000 | 3 | 1988 | 1994 | ||||
Lewy Body Disease
|
41 | 0.590 | 0.600 | 19 | 44908684 | missense variant | T/C | snv | 0.14 | 0.16 | 0.700 | 1.000 | 3 | 2014 | 2019 | ||||
Myocardial Infarction
|
680 | 0.590 | 0.600 | 19 | 44908684 | missense variant | T/C | snv | 0.14 | 0.16 | 0.030 | 1.000 | 3 | 2006 | 2019 | ||||
Presenile dementia
|
159 | 0.590 | 0.600 | 19 | 44908684 | missense variant | T/C | snv | 0.14 | 0.16 | 0.030 | 1.000 | 3 | 2001 | 2018 | ||||
C-reactive protein measurement
|
624 | 0.590 | 0.600 | 19 | 44908684 | missense variant | T/C | snv | 0.14 | 0.16 | 0.700 | 1.000 | 2 | 2018 | 2018 | ||||
Coronary Artery Disease
|
1577 | 0.590 | 0.600 | 19 | 44908684 | missense variant | T/C | snv | 0.14 | 0.16 | 0.020 | 1.000 | 2 | 2017 | 2019 | ||||
Coronary heart disease
|
1178 | 0.590 | 0.600 | 19 | 44908684 | missense variant | T/C | snv | 0.14 | 0.16 | 0.020 | 1.000 | 2 | 2011 | 2019 | ||||
Diabetes Mellitus, Non-Insulin-Dependent
|
2672 | 0.590 | 0.600 | 19 | 44908684 | missense variant | T/C | snv | 0.14 | 0.16 | 0.020 | 1.000 | 2 | 2011 | 2019 | ||||
Dyslipidemias
|
184 | 0.590 | 0.600 | 19 | 44908684 | missense variant | T/C | snv | 0.14 | 0.16 | 0.020 | 1.000 | 2 | 2014 | 2015 | ||||
Hypercholesterolemia
|
123 | 0.590 | 0.600 | 19 | 44908684 | missense variant | T/C | snv | 0.14 | 0.16 | 0.020 | 0.500 | 2 | 1993 | 2001 | ||||
Hypertensive disease
|
1085 | 0.590 | 0.600 | 19 | 44908684 | missense variant | T/C | snv | 0.14 | 0.16 | 0.710 | 1.000 | 2 | 2019 | 2019 | ||||
Low density lipoprotein cholesterol measurement
|
1142 | 0.590 | 0.600 | 19 | 44908684 | missense variant | T/C | snv | 0.14 | 0.16 | 0.700 | 1.000 | 2 | 2018 | 2018 | ||||
Mental deterioration
|
121 | 0.590 | 0.600 | 19 | 44908684 | missense variant | T/C | snv | 0.14 | 0.16 | 0.710 | 1.000 | 2 | 2017 | 2019 | ||||
Metabolic Syndrome X
|
591 | 0.590 | 0.600 | 19 | 44908684 | missense variant | T/C | snv | 0.14 | 0.16 | 0.020 | 0.500 | 2 | 2011 | 2014 | ||||
Multiple Sclerosis
|
1022 | 0.590 | 0.600 | 19 | 44908684 | missense variant | T/C | snv | 0.14 | 0.16 | 0.020 | 0.500 | 2 | 2012 | 2015 | ||||
Parkinson Disease
|
990 | 0.590 | 0.600 | 19 | 44908684 | missense variant | T/C | snv | 0.14 | 0.16 | 0.710 | 1.000 | 2 | 2014 | 2019 | ||||
Serum total cholesterol measurement
|
1243 | 0.590 | 0.600 | 19 | 44908684 | missense variant | T/C | snv | 0.14 | 0.16 | 0.700 | 1.000 | 2 | 2018 | 2018 | ||||
Waist-Hip Ratio
|
1138 | 0.590 | 0.600 | 19 | 44908684 | missense variant | T/C | snv | 0.14 | 0.16 | 0.700 | 1.000 | 2 | 2019 | 2019 |